| Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis M Principe, S Borgoni, M Cascione, MS Chattaragada, S Ferri-Borgogno, ... Journal of hematology & oncology 10, 1-13, 2017 | 121 | 2017 |
| Targeting immune dysfunction in aging S Borgoni, KS Kudryashova, K Burka, JP De Magalhães Ageing research reviews 70, 101410, 2021 | 106 | 2021 |
| The genomic and transcriptional landscape of primary central nervous system lymphoma J Radke, N Ishaque, R Koll, Z Gu, E Schumann, L Sieverling, S Uhrig, ... Nature Communications 13 (1), 2558, 2022 | 71 | 2022 |
| Depletion of tumor-associated macrophages switches the epigenetic profile of pancreatic cancer infiltrating T cells and restores their anti-tumor phenotype S Borgoni, A Iannello, S Cutrupi, P Allavena, M D'Incalci, F Novelli, ... Oncoimmunology 7 (2), e1393596, 2018 | 71 | 2018 |
| Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer Ö Saatci, S Borgoni, Ö Akbulut, S Durmuş, U Raza, E Eyüpoğlu, C Alkan, ... Oncogene 37 (17), 2251-2269, 2018 | 69 | 2018 |
| AXL and error-prone DNA replication confer drug resistance and offer strategies to treat EGFR-mutant lung cancer A Noronha, N Belugali Nataraj, JS Lee, B Zhitomirsky, Y Oren, S Oster, ... Cancer discovery 12 (11), 2666-2683, 2022 | 51 | 2022 |
| Integrating proteomics into precision oncology LW Wahjudi, S Bernhardt, K Abnaof, P Horak, S Kreutzfeldt, C Heining, ... International journal of cancer 148 (6), 1438-1451, 2021 | 26 | 2021 |
| Extracellular vesicles orchestrate immune and tumor interaction networks KHW Yim, A Al Hrout, S Borgoni, R Chahwan Cancers 12 (12), 3696, 2020 | 23 | 2020 |
| Abrogating GPT2 in triple‐negative breast cancer inhibits tumor growth and promotes autophagy D Mitra, S Vega‐Rubin‐de‐Celis, N Royla, S Bernhardt, H Wilhelm, ... International journal of cancer 148 (8), 1993-2009, 2021 | 18 | 2021 |
| Stromal NRG1 in luminal breast cancer defines pro-fibrotic and migratory cancer-associated fibroblasts M Berdiel-Acer, A Maia, Z Hristova, S Borgoni, M Vetter, S Burmester, ... Oncogene 40 (15), 2651-2666, 2021 | 15 | 2021 |
| Serum extracellular vesicles profiling is associated with COVID‐19 progression and immune responses KHW Yim, S Borgoni, R Chahwan Journal of Extracellular Biology 1 (4), e37, 2022 | 14 | 2022 |
| Time-resolved profiling reveals ATF3 as a novel mediator of endocrine resistance in breast cancer S Borgoni, E Sofyalı, M Soleimani, H Wilhelm, K Müller-Decker, R Will, ... Cancers 12 (10), 2918, 2020 | 12 | 2020 |
| Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2-breast cancer M Soleimani Dodaran, S Borgoni, E Sofyalı, PJ Verschure, S Wiemann, ... BMC cancer 20, 1-15, 2020 | 10 | 2020 |
| Host-dependent phenotypic resistance to EGFR tyrosine kinase inhibitors Y Haga, I Marrocco, A Noronha, ML Uribe, NB Nataraj, A Sekar, ... Cancer research 81 (14), 3862-3875, 2021 | 4 | 2021 |
| Stromal NRG1 in luminal breast cancer defines pro-fibrotic and migratory cancer-associated fibroblasts M Berdiel-Acer, A Maia, Z Hristova, S Borgoni, M Vetter, S Burmester, ... bioRxiv, 2020.04. 06.026971, 2020 | 2 | 2020 |
| Clonal heterogeneity in ER+ breast cancer reveals the proteasome and PKC as potential therapeutic targets L Beumers, EI Vlachavas, S Borgoni, L Schwarzmüller, L Penso-Dolfin, ... NPJ Breast Cancer 9 (1), 97, 2023 | 1 | 2023 |
| Serum extracellular vesicles trace COVID-19 progression and immune responses KH Wai Yim, S Borgoni, R Chahwan medRxiv, 2022.01. 19.22269529, 2022 | 1 | 2022 |
| Commentary:" Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis" M Principe, S Borgoni, F Novelli Journal of Rare Diseases Research & Treatment 2 (5), 2017 | 1 | 2017 |
| Modular cytosine base editing promotes epigenomic and genomic modifications J Weischedel, L Higgins, S Rogers, A Gramalla-Schmitz, P Wyrzykowska, ... Nucleic Acids Research 52 (2), e8-e8, 2024 | | 2024 |
| Clonal heterogeneity in ER+ breast cancer reveals the proteasome and PKC as potential therapeutic targets S Wiemann, L Beumers, E Vlachavas, S Borgoni, L Schwarzmüller, ... | | 2023 |
